ReviewCancers2022

Clinical Landscape of PARP Inhibitors in Ovarian Cancer: Molecular Mechanisms and Clues to Overcome Resistance.

Satoru Kyo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.